CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2019; 55(01): 003-005
DOI: 10.1055/s-0039-1694070
Review Article
National Academy of Medical Sciences (India)

Musculoskeletal Tuberculosis: A Multifaceted Foe

Uma Kumar
1   Department of Rheumatology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
,
Sauvik Dasgupta
1   Department of Rheumatology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
› Author Affiliations
Further Information

Publication History

Publication Date:
02 October 2019 (online)

Abstract

Tuberculosis (TB) still remains a global epidemic, and India accounts for one-fourth of the world's TB burden. The incidence of extrapulmonary TB has relatively remained constant, but with the introduction of antitumor necrosis factor, there has been a surge in pulmonary and extrapulmonary TB cases presenting to rheumatologists. Musculoskeletal TB accounts for 10 to 30% of all cases of extrapulmonary TB, with spondylitis (Pott's spine) being the most common manifestation. Manifestations mimicking autoimmune spondylitis are seen in 10% of cases. Tubercular arthritis most commonly presents with large joint monoarthritis, but oligo- or polyarticular involvement is also seen. Poncet's disease is a form of reactive arthritis occurring in patients with pulmonary or extrapulmonary TB, which is rarely seen with good response to antitubercular treatment. Quite often, there is delay in the diagnosis of musculoskeletal TB due to absence of constitutional symptoms. Treatment of musculoskeletal TB involves prolonged course of antitubercular treatment, and surgical interventions are limited to special cases.

 
  • References

  • 1 Central Tuberculosis Division, Government of India. Available at: http://tbcindia.gov.in/WriteReadData/tbIndia2017.pdf . Accessed July 10, 2019
  • 2 Keane J, Gershon S, Wise RP. et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345 (15) 1098-1104
  • 3 Dixon WG, Hyrich KL, Watson KD. et al; B S R B R Control Centre Consortium; BSR Biologics Register. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) Ann Rheum Dis 2010; 69 (03) 522-528
  • 4 Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res 2004; 120 (04) 316-353
  • 5 Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009; 49 (09) 1350-1357
  • 6 Rueda JC, Crepy MF, Mantilla RD. Clinical features of Poncet's disease. From the description of 198 cases found in the literature. Clin Rheumatol 2013; 32 (07) 929-935
  • 7 Macía VillaC, Sifuentes GiraldoW, Boteanu A, González LanzaM, Bachiller CorralJ. Reactive arthritis after the intravesical instillation of BCG. Reumatol Clin 2012; 8 (05) 284-286
  • 8 Tsay MH, Chen MC, Jaung GY, Pang KK, Chen BF. Atypical skeletal tuberculosis mimicking tumor metastases: report of a case. J Formos Med Assoc 1995; 94 (07) 428-431